Eylea® Aflibercept Biosimilar ALT-L9

Eylea® Aflibercept Biosimilar ALT-L9
Product Description

Indications: Wet Age-related Macular Degeneration (wAMD). Currently in global phase III and to be launched by 2025. Same cell line used by originator and has a high level of similarity in PK profile in human studies. ALT-L9 has a unique formulation with improved thermal stability with process patents registered in Korea, Japan, Russia, Australia, China, USA and EU. Pre-filled Syringe launch is also expected.

Alteogen

  • KR
  • 2023
    On CPHI since
Specifications
  • Supplied from
    Korea, Republic Of

Alteogen

  • KR
  • 2023
    On CPHI since

More Products from Alteogen (2)

  • Novel Hyaluronidase (ALT-B4) Hybrozyme™

    Product Novel Hyaluronidase (ALT-B4) Hybrozyme™

    A novel and proprietary hyaluronidase to enable subcutaneous administration of IV biologics. Currently partnered with 4 global pharmaceutical companies including two Top 10 global pharmaceutical companies. ALT-B4 has enhanced thermal stability and protein stability leading to longer shelf-life, has higher ...
  • Novel Hyaluronidase Human Injection Tergase®

    Product Novel Hyaluronidase Human Injection Tergase®

    Novel hyaluronidase exhibiting enhanced properties - higher tolerance to thermal stress, specific activity and productivity and lower immunogenicity. Indications in dermatology, ophthalmology, pain management and plastic surgery. Tergase® is a substantially better alternative to animal-derived hyaluronidas...

Alteogen resources (1)

Recommended Products

  • Product INJECTABLES

    Requiring injectables.EU-GMP is a must.
    EU dossier is a must.
    Licensing and supply model or distributorship.
  • Product medEctoin Sicca Eye Drops + HA

    Medical device for treatment and prevention of dry eyes symtoms. • Moistens dry and irritated eyes  • Reduces burning and itching  • Stabilizes the lipid layer of the tear film and reduces further dehydration • Protects ocular cells from hyperosmolarity • Also effective as preventive t...
  • Product Custom Protein Synthesis

    We provide a Custom Protein Synthesis Service, using a chemical method that synthesises proteins amino acid by amino acid and making modifications on an atomic-scale. We work closely with our partners in designing, customising and optimising the proteins that is synthesized in an automa...
  • Product Pipeline

    Polpharma Biologics has its own pipeline of biosimilars for out-licensing.
    We are focused on advancing and expanding our product portfolio to increase patient access to these much-needed therapies and are open to partnering with other organizations to co-develop or commercialize our biosimilars.
  • Product Biologic drug substance CDMO services

    From pre-clinical development to commercial supply, Patheon by Thermo Fisher Scientific is an industry leader in the development and manufacture of mammalian cell culture drug substances. Patheon offers biotech and pharmaceutical companies the ability to pursue opportunities around the globe with a fully i...
  • Product VitiPure P 188

    VitiPure™ P 188 (Poloxamer 188) is a multi-talented solubilizer for variety of applications with well established safety & toxicology  profile via several marketed drugs world-wide. It complies with Ph. Eur & USP standard. 
  • Product Biologics

    End-to-end development and manufacturing capabilities across different therapeutic modalities and the entire product lifecycle

    Cutting-edge technology platforms for high yielding cell lines (both mammalian and microbial) and high concentration formulations


    Integrated and flexible drug sub...
  • Product Biotechnology Services

    Midas Pharma offers a wide range of pharmaceutical services which include biotechnology services. It offers:  • development of biosimilars and proprietary biologicals (starting from gene sequence) • cGMP production (microbial and mammalian cells) • related bioanalytics (from protein biochemical meth...
  • Product Biosimilars Testing Services

    Testing services for biosimilars: Our biosimilar analytical comparability programs provide highly relevant data for early stage characterisation and later stage comparison. These programs evaluate and compare all pertinent features of the biosimilar product and are based on the ICH Q6B. Programs encompa...
  • Product Biosimilars, and High Value Molecules

    Lodaat has an extensive portfolio of Biosimilars, Biologics, and High Value Molecules including ADCs, MABs and other large molecules.  We are looking for reputable global partners who want to expand their product line and in-license for their territory.
  • Product Romiplostim Biosimilar Candidate

    Due to the complex nature of the product, Paras Biopharmaceuticals has been intensively working on this complex drug (Nplate™) for over 6 years and has progressively achieved success. The company plans to mature good value within its Romiplostim asset (Biosimilar) and would like to highlight the following...
  • Product Epokine Inj. (rh-EPO)

    Anemia of hemodialysis patients with end-stage renal disease
  • Product Gamma Irradiated Cleanroom Facemasks With Tyvek Side Extensions

    Gamma Irradiated, Extra Large Cleanroom Facemask with Tyvek® Side Extensions, Green or Blue, with Double Elastic Headbands and with or without Fog-Prevention Adhesive are made from an inner facing of soft cellulose material, an outer facing of spunbonded polypropylene and a 100% meltblown polypropylene med...
  • Product Remsima

    The world's 1st mAb biosimilar • Ingredient: Infliximab • Indication: Rheumatoid arthritis, inflammatory bowel disease • Mode of mechanism: Relieves disease progression by inducing a neutralizing response to tumor necrosis factor(TNF-α), the cause of autoimmune disease • Approval status: 100 countri...
  • Product Kemwell Biopharma

    SERVICES Kemwell provides integrated development and manufacturing services for companies that require one-stop solution for mammalian cell-culture based protein therapeutics The team is experienced to undertake end-to-end activities right from cell line development till cGMP clinical and commercial manufa...
  • Product Ready to use cell lines

    Ready to use cell lines
  • Product Products in Private Label

    We offer customers a complete range of medical devices for nasal and eye care, ready for customisation with the graphics and brand of the distributor. They are CE-marked and can be sold in EU and non-EU countries, once they have been registered locally.
  • Product Rituximab

    Rituximab binds itself to the CD20 protein, marking them, and subsequently triggering the cells of the immune system to pick out the marked cells and kill them.The indication is for Non Hodgkin Lymphoma
  • Product Eylea biosimilar vial & PFS

    1.Completion of global clinical trials phase Ⅲ 
    2. Completion of pre-submission meetings with advanced regulatory authorities
    3. Available in Vial and PFS
  • Product Interview by Newsweek, time to talk

    Interviewee:Dr. Steve J.P. Hsu (President of Genovior Biotech)
  • Product Biosimilars Portfolio

    • Pegfilgrastim (Filed with EMA) • Filgrastim (Filed with EMA) • Trastuzumab (Filed with EMA, MHRA, Received recommendation for marketing authorization in India) • Bevacizumab (Filed with MHRA) • Omalizumab (Global PhIII ongoing) • Denosumab (Global PhIII ongoing) • Ranibizumab (Global PhIII ongoing...
  • Product Method Development

    We are specialist in the method development of analytical methods for analysis of API, Final Drug Products or low level impurities. Usually followed by full validation in accordance to ICH guidelines.
  • Product Sterile Grade at ISO Class 5 facility

    Kikkoman can offer "sterile grade” products, purified through a super purification process at our ISO Class 5 facility, approved by the Japanese Authority. 
  • Product Mipeginterferon alfa-2b

    Pegylated human interferon alfa-2b

    Trade name: PEGBING

    Technology
    Recombinant gene technology, expressed by Yeast

    Amino acid
    165 amino acids

    Molecular weight
    Approximately 59 kD

    Indications
    Chronic hepatitis B & C

    ...
  • Product HANBEITAI (Bevacizumab Injection)

    HANBEITAI (generic name: bevacizumab), the fourth product independently developed by Henlius, received marketing approval from the National Medical Products Administration (NMPA) in November 2021, and its commercialization in Chinese mainland is handled by the company's in-house team. As of now, HANBEI...
  • Product Basalin®(insulin glargine injection)

    Basalin® is an insulin glargine injection developed and produced independently by Gan & Lee Pharmaceuticals. It was launched in China in 2005 and has been approved in almost 20 countries globally. As a long-acting biosimilar insulin, Basalin® is able to stablely control human blood sugar within 24...
  • Product Pharmaceutical and Biological Products Contract Development and Manufact...

    Bora Pharmaceuticals is a premier international contract development and manufacturing organization (CDMO). Our six state-of-the-art cGMP manufacturing facilities across Asia and North America deliver to more than 100 markets around the world. Our sites have the highest industry standards for quality, dev...
  • Product Protamine sulfate

    Prjsc "Indar" provides wide range of antidotes products which includes protamine sulfate. The product is an efficient antidote to heparin of equivalent dosage: 1 mg of protamine sulfate neutralizes 1 mg of heparin. The effect occurs instantly (“on the needle”) and lasts for approximately 2 hours. Is usuall...
  • Product Biosimilars

    Portfolio of high-producing biosimilar cell lines and processes, off-the-shelf and generation of such from scratch. Biosimilarity optimisation of your recombinant cell line. Your benefit: Cost and time-savings, while bringing your product to the market. https://excellgene.com/offerings/biosimilars/
  • Product Ficocyte

    Filgrastim 30 MU /0.5 ml   It is a synthetic version of a certain natural substance made in human body. It helps the bone marrow to produce new white blood cells. Filgrastim is given to people whose ability to produce white blood cells is reduced, due to chemotherapy, chronic neutropenia, or exp...
  • Product Leuprolide 3-Month Implant

    The active ingredient leuprorelin, like goserelin, is a synthetic peptide that can be used primarily in the treatment of hormone-dependent tumors, particularly prostate cancer. Administration of leuprorelin has indirect effects on testosterone levels in men, the lowering of which stops the growth of malign...
  • Product EPIDEXONE ® (dexamethasone)

    EIPICO offers a wide range of corticosteroids which includes epidexone ®, dexamethasone. It belongs to sensory organs(ophthalmologicals)/corticosteroids categories. Contact us for more information.